EP2696853B1 - Surface induced disassembly of nano containers - Google Patents

Surface induced disassembly of nano containers Download PDF

Info

Publication number
EP2696853B1
EP2696853B1 EP12723933.3A EP12723933A EP2696853B1 EP 2696853 B1 EP2696853 B1 EP 2696853B1 EP 12723933 A EP12723933 A EP 12723933A EP 2696853 B1 EP2696853 B1 EP 2696853B1
Authority
EP
European Patent Office
Prior art keywords
disassembly
micelle
conducting polymer
release
guest molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP12723933.3A
Other languages
German (de)
French (fr)
Other versions
EP2696853A1 (en
Inventor
Kothandam Krishnamoorthy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of EP2696853A1 publication Critical patent/EP2696853A1/en
Application granted granted Critical
Publication of EP2696853B1 publication Critical patent/EP2696853B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

    Technical field of invention:
  • The present invention discloses stimuli induced disassembly of nano containers by charged surface. Particularly, the present invention provides stimuli induced disassembly of nano containers by polyvalent interaction between surfactant assemblies and delocalized charges of an insoluble polymer to trigger the disassembly for site specific delivery of guest molecules.
  • Background and prior art:
  • The nanomaterials based on polymers and amphiphilic self-assembling systems are reported in the literature. The amphiphilic molecules are defined as molecules with exterior hydrophilic end and hydrophobic interior that arrange themselves at interfaces to build aggregates in solution. Further the amphiphiles are surface active molecules; which lower the surface tension, thereby lowering the energy of the system.
  • Nanoassemblies of amphiphilic molecules are promising candidates for payload encapsulation and delivery at desired locations. Delivery of the payload is initiated by disassembly of nanoassemblies in response to stimulus such as temperature, pH, magnetic field, ultrasound, redox, proteins and enzymes.
  • The polymer-micelle complex has standard ability to tune the core and shell components, such complexes particularly useful for drug delivery because the core of the assembly can serve as a reservoir for a variety of therapeutic agents while the hydrophilic shell imparts solubility and stability to the aqueous assemblies.
  • Polymer-micelles are vital due to their ability to deliver large payloads of a variety of drugs (e.g. biomolecules, dyes, drugs, proteins, enzymes and DNA/RNA therapeutics), and their improved in vivo stability as compared to other colloidal carriers (e.g. liposomes), and their nanoscopic size which allows for passive accumulation in diseased tissues, such as solid tumors, by the enhanced permeation and retention (EPR) effect. The polymer micelle complex can actively target diseased cells and aid in cellular entry, resulting in improved cell specific delivery.
  • United States Patent Application No. 20090081457 discloses a polymer-micelle complex suitable for use as an aid to preparing fibers, particularly nanofibers, by electrospinning wherein the polymer is selected from the group consisting of polyethylene oxide (PEO); polyvinyl pyrrolidone (PVP); polyvinyl alcohol (PVOH); polyamides (PA); polyacrylonitrile (PAN); polyaniline (PANI)-PEO; PANI/polystyrene (PS); the material may be contained within the micelle, itself, which may be desirable if the material is a drug, an enzyme or other material whose activity one wishes to control and the surfactants may include ionic surfactants and nonionic surfactants depending upon the type of solvent and the type of polymer.
  • US7638558 relate to a drug-loaded micelle comprising a tri-block copolymer, wherein said micelle has a drug-loaded inner core, a crosslinked outer core, and a hydrophilic shell, wherein the multi-block copolymer comprises a polymeric hydrophilic block, a crosslinked poly (amino acid block), and a poly (amino acid block), characterized in that said micelle has an inner core, a crosslinked outer core, and a hydrophilic shell.
  • Applications of electrospun fibers in drug delivery, wherein both degradable and non-degradable polymers are to be developed as drug carriers for local delivery of antibiotics and anticancer drugs, by using electrospun fibrous materials with different structures are disclosed in Sci. Technol. Adv. Mater by Wenguo Cui et al. 11 (2010) 014108 (11pp).
  • Nanocontainers, such as Tobacco mosaic virus, zeolites, biological vesicles, polymeric nanogels, solid lipid nanoparticles, or self-assembled peptides, that protect the drug from enzymatic degradation and are sensitive to external stimuli, e.g. heat and pH change, which control the release of chemotherapeutic drugs are disclosed in 'Magnetic Nanocontainers for Combined Hyperthermia and Controlled Drug Release Project' Articles.
  • United States Patent Application No. 20110229565 discloses a drug-delivery composition comprising a drug-derived or prodrug-derived gelator which can be released upon a stimulus wherein stimuli can be ultrasound, temperature, pH, metal ions, light, electrical stimuli, electromagnetic stimuli, and combinations thereof. It also discloses dye encapsulated self-assembled nanofibers, in vitro and in vivo analysis.
  • Technical report, Polymer Engineering and Science by Wu, Tzong-Ming et al, 04,2008;(48)(40) discloses preparation of doped polyaniline in its emeraldine salt form (PANI-ES) by in situ chemical oxidative polymerization using various concentrations of sodium dodecyl sulfate (SDS) micellar solutions and the synthesis, processing and applications of polyaniline (PANI) conducting polymer, over the other conducting polymers (ICPs) is reported in 'Progress in Polymer Science' 34(8),08-2009 (783-810) by Sambhu Bhadraa et al.
  • The effect of polyaniline on the size and shape of sodium dodecyl sulfate (SDS) micelles is disclosed in Langmuir, 2004, 20 (12) (4874-4880) and Chemistry Letters Vol. 37 (8) 858; 2008.Further enzyme, protein triggered disassembly of dendrimer-based amphiphilic nanocontainers reported in J. Am. Chem. Soc by Azagarsamy, 2009, 131 (40) (14184-14185).
  • Additionally, Yajuy n Wang in Phys. Chem. Chem. Phys, 2011, (13),4782-4801 discloses nanostructured polymer assemblies formed at interfaces to generate materials with specific properties and functions for application in diverse fields, including biomaterials, drug delivery, catalysis, sensing, optics and corrosion.
  • In view of above, it is clear that the delivery of an effective concentration of drug at the right time and at the right place can minimize systemic adverse reactions, reduce drug dosage and eventually lower the cost and improve therapeutic outcome and patient compliance. Research into stimuli-responsive polymers as a means of achieving this is steadily gaining momentum and more novel polymers are being synthesized to be incorporated into innovative delivery systems intended for site-specific and self-regulated drug delivery. These stimuli-responsive polymers are also immensely valuable in applications such as bioseparation of proteins and other bio-particles for basic life science research as well as industrial applications.
  • In all these approaches, the molecules that form the assembly are suitably designed and synthesized to respond to the stimulus, however, fails to teach site specific delivery. Further, many of the existing methods relate to doped conducting polymer assembly or in the form of gelator, where the viscosity of solution is decreased with increasing concentration of the surfactant.
  • In view of the above, there is still a need to find new composition with enhanced performance over the existing delivery systems facing the demand of industry for increasingly sophisticated systems for site specific delivery of guest molecules. The present research trends in stimuli-responsive systems are focused on the employment of smart polymers such as charge conducting polymer in order to achieve site-specific delivery of guest molecule which relies solely on a stimulus specific to that region
  • Therefore, the objective of the present invention is to provide stimuli induced nano containers obtained by charged surface disassembly of amphiphilic molecules as promising candidates for payload encapsulation and delivery at desired location.
  • Summary of the Invention:
  • An example relates to a composition for stimuli induced disassembly of nanocontainer useful for site specific delivery comprising insoluble cationic oxidised conducting polymer; micelle assembly and guest molecule; wherein site specific delivery of guest molecule is achieved by polyvalent interaction between micelle assemblies and delocalized charges of polymer to trigger the disassembly.
  • The cationic oxidised conducting polymer may be selected from polythiophene (PTs), polypyrrole (PPy), and Poly(3,4-ethylenedioxythiophene) poly(styrenesulfonate) (PEDOT/PSS), polyaniline (PANI), polystyrene (PS) in the range of 1-50% by weight of the composition.
  • The cationic oxidised conducting polymer may be in bulk, nano, film, patch or device form.
  • The cationic oxidised conducting polymer may be polyaniline (PANI).
  • The cationic oxidised conducting polymer may be Poly(3,4-ethylenedioxythiophene).
  • The micelle assembly may comprise ionic micelle at its CMC.
  • The guest molecule may be a hydrophobic molecule, not more than 1% by weight of the composition.
  • The guest molecule may be selected from drugs, dyes, small molecules, biomolecules, proteins and like thereof.
  • The said composition may be recyclable.
  • In one aspect, the present invention provides a process for preparation of stimuli induced disassembly of nanocontainer comprising of;
    1. a) dissolving ionic micelle in a solvent at its CMC to form a solution of micelle assembly;
    2. b) adding a guest molecule to the solution of step (a); and
    3. c) disassembly of the micelle assembly and concomitant release of the guest molecule by addition of an oxidized conducting polymer.
  • One of the feature of the invention is wherein said process is recyclable.
  • The present invention relates to stimuli induced disassembly of nanocontainer useful for site specific delivery comprising insoluble cationic oxidised conducting polymer; micelle assembly and guest molecule; wherein site specific delivery of guest molecule is achieved by polyvalent interaction between micelle assemblies and delocalized charges of polymer to trigger the disassembly.
  • Abbreviations:
    • DLS: Dynamic light Scattering
    • SDS: Sodium dodecyl sulfate
    • TEM: Transmission Electron Microscopy
    • PANI: Polyanilline
    • (OxCP): Oxidised conducting polymer
    • (RedCP): Reduced conducting polymer
    • (NeuCP):Neutral conducting polymer
    • (CTAB): Cetyl-trimethyl ammonium bromide
    Description of drawings:
    • Fig 1: Figure 1 depicts interaction between cationic oxidized conducting polymer (OxCP) and anionic micelle.
    • Fig 2: Figure 2 shows interaction between micelle encapsulated with guest molecule and charged, rigid surface of conducting polymer.
    • Fig 3: depicts DLS of SDS micelle assembly
    • Fig 4: depicts disassembly of SDS micelle by oxidized PANI
    • Fig 5: Figure 5 shows interaction of Ox PANI with anionic arid cationic micelles
    • Fig 6: depicts TEM image of PANI nanofibre
    • Fig 7: depicts Release of pyrene using PANI and Nanofibre PANI
    • Fig 8: depicts % release vs number of cycles
    • Fig 9: Release of guest molecule (Nile red) from micelles using poly(3,4-ethylenedioxythiophene) as a function of time. Decrease in emission intensity as function of time indicates release of guest molecule.
    • Fig 10: Release of guest molecule (Nile red) from micelles using polyaniline as a function of time. Decrease in emission intensity as function of time indicates release of guest molecule.
    • Fig 11: Release of guest molecule (Nile red) from DBS micelles using oxidised polyaniline as a function of time. Decrease in emission intensity as function of time indicates release of guest molecule.
    Detailed description of invention:
  • The present invention describes stimuli (such as temp, pH, ultrasound etc) induced disassembly of nanostructure by using charged polymer surface, wherein nanostructure encapsulated with hydrophobic guest molecule or encapsulant is released at desired location in short time. The nanostructures for targeting delivery of encapsulant are selected from lipid-based liposomes and micelles, protein-based dendrimers and polymer-based nanovectors such as nanoparticles, nanospheres and nanocontainers.
  • In an embodiment, present invention provides a process for stimuli induced disassembly of nanocontainer useful for site specific delivery comprising insoluble cationic oxidised conducting polymer; micelle assembly and guest molecule; wherein site specific delivery of guest molecule is achieved by polyvalent interaction between micelle assemblies and delocalized charges of polymer to trigger the disassembly. Insoluble cationic oxidised conducting polymer of the invention is insoluble in the micelle solution.
  • Accordingly the present inventors evaluated the interaction between insoluble cationic oxidized conducting polymer (OxCP) and ionic micelle using DLS, wherein the micelle assembly size is reduced from 6 nm to 1 nm due to polyvalent interaction, on the other hand no anionic micelle disassembly is observed in presence of neutral conducting polymer (NeuCP) as shown in figure 1.
  • In an embodiment the insoluble cationic oxidized conducting polymer is selected from the group comprising of polythiophene (PTs), polypyrrole (PPy), and Poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) PEDOT/PSS. polyaniline (PANI), polystyrene (PS), wherein polyaniline is especially attractive among them because it is less expensive, has three distinct oxidation states with different colors and has good acid/base doping response. The polymer is used in the composition in the range of 1-50 by weight of composition.
  • The nanoassembly comprises of ionic micelles including cationic surfactants, such as cetyl-trimethyl ammonium bromide (CTAB) and dodecyl trimethylammonium bromide (DTAB) and anionic surfactant such as do decyl benznene sulphoneate (DBS) and sodium dodecyl sulfate (SDS) with known critical micelle concentrations (CMC) and surfactant aggregation numbers, preferably anionic micelle sodium dodecyl sulfate (SDS). The ionic micelle is used at its CMC.
  • In yet another embodiment, the guest molecule is hydrophobic selected from drug, dye, small molecules, biomolecule, protein and like thereof. Further the hydrophobic chemotherapeutic drug is selected from anticancer agent, antihistamic agent, antibacterial agent, antifungal agent, CNS, cardiovascular, antibiotic agent, NSAID and anti-inflammatory agent. The guest molecule is used in the nano container of the invention at not more than 1% by weight of composition.
  • In yet another embodiment, the process of the invention wherein stimuli induced nanocontainers obtained by charged surface disassembly of amphiphilic molecules are used as candidates for payload encapsulation and delivery at desired locations comprises: oxidized polymer bearing positive charge as surface to induce disassembly of nanoscopic containers having anionic charges on the solvent exposed exterior and hydrophobic interior, and wherein the nanoscopic containers have sequestered hydrophobic guest molecules.
  • In another embodiment, the present invention provides process for preparation of stimuli induced disassembly of nanocontainer comprising step of;
    1. a) dissolving ionic micelle in solvent at its CMC to form micelle assembly;
    2. b) adding guest molecule to solution of step (a) at a concentration of not more than 1% by weight of the composition; and
    3. c) disassembly of micelle and concomitant release of guest molecule by addition of oxidized conducting polymer at 1-50% by weight of the polymer composition..
  • The soft template synthesis, also named self-assembly method, employs micelles formed by surfactants to confine the polymerization of conducting polymers into low dimensional nanomaterials.
  • In yet another embodiment the conducting polymer of the present invention is in the form selected from, bulk form, nano form, film, patch, device and like thereof, wherein the release or delivery of candidates from the composition is independent of the form of the composition.
  • According to the embodiment the oxidizing conducting polymer nanofibres are ranging from 20-200 nm in diameter, particularly nanofibres of PANI (Fig.6), whereas the size of nanoassembly of anionic micelles is in the range of 0.1 to 5 nanometers in diameter. The anionic micelles employed in the present invention having diameter in the range of 2-20 nm.
  • Further the present process finds various applications such as pharmaceuticals, biological applications and nanotechnology. Compositions may be administered orally, parenterally, by inhalation spray, by nasal aerosol or inhalation, topically, rectally in the form of suppositories, nasally, buccally, vaginally or via an implanted reservoir, wherein parenteral administration includes subcutaneous, intravenous, intramuscular, intra-articular,intra-synovial, intra sternal, intrathecal, intrahepatic, intralesional and intracranial injection or infusion techniques.
  • The pharmaceutically acceptable compositions may be orally administered in any orally acceptable dosage forms such as to granules, pellets, beads, seeds, capsules, tablets, oral aqueous suspensions, solutions, dry syrup, oral liquids etc. which can be formulated in the immediate or sustained or controlled or delayed release dosage forms or combinations thereof.
  • In another embodiment, the conducting polymer surface can be made neutral by reversing the potential therefore one would be able to reuse the substrate for release of guest molecule. Thus the process of the invention is recyclable. With reference to figure 8, the nanoassembly based composition of example 1 is recycled up to 6-10 times wherein the release of guest molecule is more than 50%.
  • The advantages of nano-sized encapsulation devices are numerous. For example, when compared to single molecule drugs or diagnostic agents, "nanocontainers" can transport much larger quantities of such agents. Nanoscopic drug delivery systems are generally more apt to elude biological barriers, resulting in reduced inactivation or excretion of the encapsulated therapeutic. Multi- functionality is a common feature of nanovectors whereby multiple drugs, diagnostic agents, and targeting groups can be packaged into a single system. The bottom-up design of nanoscopic drug delivery systems often
    involves the precise self-assembly of single molecules or polymeric units to create complex, multi - functional devices. Further the conducting polymers can be synthesized easily by applying a small potential on an electrode using the corresponding monomer, wherein the polymer can also be made neutral by reversing the potential. Therefore, one would be able to reuse the substrate for release of guest molecules particularly the electrode can be reused over a period of five to seven days.
  • Polymer micelles present a viable alternative, which offer considerable tuning of the micelle size and surface functionality. The present inventors have demonstrated that the anionic surfactants which formed the micelles has modified the surface of oxidised conducting polymer that can be used for "site specific delivery of guest molecules"
    Following examples are given by way of illustration.
  • Experimental: Dynamic Light Scattering study (DLS):
  • DLS is used to characterize size of various particles including proteins, polymers, micelles, carbohydrates, and nanoparticles wherein the measurement depends on the size of the particle core, the size of surface structures, particle concentration, and type of ions in the medium. The stimuli induced disassembly of nanocontainers is studied using DLS, wherein the 6 mM sodium dodecyl sulfate solution is evaluated which is in the range of 2-20 nm, particularly 6 nm (Fig.3). However on accession of oxidised coducting polymer i.e polyaniline the change in SDS assembly size is determined which is in the range of 0.1-5 nm, particularly 1 nm, essentially indicating the absence of any nanoscale assemblies in the solution (Fig.4).
  • The Fig. 5 indicates comparative assembly size of present SDS micelle with OxPANI and cationic micelles (i.e. CTAB) with reduced and oxidised polyaniline, The present inventors inferred from due experiments that the cationic micelles such as CTAB with reduced and oxidised polyaniline indicates the poor polyvalent interaction, where the assembly size is in the range of 5-8nm.However the SDS in water shows the aggregate size of 2-6 nm at critical micelle concentration.
  • UV-Vis Spectroscopy study (UV-vis):
  • Uv-vis spectroscopy is used to quantify the amount of guest molecule released from disassembly of the SDS micelles upon interaction with conducting polymer.The disassembly and concominant release of sequestered guest molecules are evaluated as function of time, which exhibits multiple emission peaks and ratio of the peak intensity at 372 nm (I372) to that at 393 nm (I393). It is observed that the guest molecule in SDS assembly corresponds to hydrophobic enviourment which on addition of OxCP to assembly provides hydrophilic enviourment to the encapsulant.This change in the enviourment is due to the disassembly of SDS micelles and concomitant release of cloistered molecule or encapsulant into water.
  • The present inventors studied the disassembly and concomitant release rate of SDS micelles with different forms of OxCP (Fig.3) wherein the SDS assembly on OxCP nanofibres starts the release of the guest molecule in 15 minutes which is faster by about two times as compared to the bulk OxCP release whereas in presence of NeuCP nanofibres, it shows infinitesimal release, Accordingly the interaction of CTAB micelles with OxCP and NeuCP nanosized fibres are studied , which indicates neither disassembly nor any subsequent release of encapsulated guest molecules.
  • The invention will now be illustrated with help of examples.
  • Example 1:
  • Sodium dodecyl sulfonate (SDS) was chosen as the ionic micelle to interact with the cationic oxidised conducting polymer (OxCP), Polyaniline (PANI). The surface induced heterogeneous disassembly process was studied using dynamic light scattering (DLS). The aggregate size of 6 mM SDS solution was found to be 6 nm ( Figure 3 ). To 5 ml SDS solution in water, 100 mg of dry OxCP (PANI) powder was added and these quantities were maintained in all forthcoming experiments. Upon accession of oxidised polyaniline, the change in SDS assembly size was determined to be 1 nm, essentially indicating the absence of any nanoscale assemblies in the solution ( Figure 4 ).
  • Example 2:
  • This example was generated to determine whether the disassembly is due to the attractive interaction between the positive charges of OxCP and negative charges of the SDS. If so, the assemblies should not break apart in presence of neutral conducting polymer (NeuCP). NeuCP was added to the SDS micelle solution and the assembly size was determined by DLS. The size of the assemblies was found to be 6 nm and remained constant over the period of monitoring. Refer figure 3.
  • Example 3: Delivery of molecules using pyrene
  • The disassembly and concomitant release of sequestered guest molecules were surveyed as a function of time using pyrene, which exhibits multiple emission peaks and the ratio of the peak intensity at 372 nm (I372) to that at 393 nm (I393). 1 micro molar solution of Pyrene in water was entrapped in SDS assemblies and I372/I393 was determined to be 0.87, which corresponds to the presence of pyrene in hydrophobic environment. Upon addition of OxCP to the pyrene sequestered SDS assemblies the I372/I393 started increasing from 0.87 and reached a value of 1.09 in 60 minutes, which indicated that the new environment facing pyrene was hydrophilic. This change in the environment of pyrene is due to the disassembly of SDS micelles and concomitant release of cloistered pyrene into water. The same experiment was carried out using NeuCP and no alteration in I372/I393 of pyrene was observed, which corroborates that the assemblies is intact in presence of NeuCP.
  • Example 4:
  • UV-vis spectroscopy was used to quantify the amount of pyrene released from the disassembly of the SDS micelles upon interaction with OxCP bulk powder. About 96% of pyrene was released upon the disassembly of nanoscopic containers and the release profile is shown in Figure 7 . The unaltered UV-vis spectral features of pyrene indicate that the SDS micelles didn't disassemble and release the guest molecules in presence of NeuCP.
  • Example 5: Variation in release kinetics as function of OxCP surface morphology
  • OxCP nanofibres were synthesized by interfacial polymerization, having diameter about 50 nm (Figure 6). 100 mg nanofibres were then added to the SDS micelle solution and the dimension of the assemblies was determined. The 6 nm assemblies were disassembled to 1 nm, which is roughly the size of the monomer. To survey the rate of the release, these nanosized fibres were added to pyrene encapsulated SDS micelles and I372/I393 of pyrene was monitored as a function of time. We noted that the disassembly and concomitant release started in 15 minutes, which is faster by about two times as compared to the bulk OxCP release. A control experiment was done using NeuCP nanofibre, which showed infinitesimal release. We also studied the interaction of CTAB micelles with OxCP and NeuCP nanosized fibres, which neither showed any disassembly nor any subsequent release of encapsulated guest molecules. Refer figure 7.
  • Example 6:
  • The disassembly and concomitant release of sequestered guest molecules were surveyed as a function of time using nile red. To a 6mMolar solution of SDS in water, 1 micromolar solution of nile red in water was added followed by addition of 100 mg of bulk powder of Poly(3,4-ethylenedioxythiophene). The release of Nile red was studied as a function of time on addition of polymer by monitoring the intensity at 670nm and the result is depicted in figure 9. Decrease in emission intensity as function of time indicates release of guest molecule.
  • Example 7:
  • The disassembly and concomitant release of sequestered guest molecules were surveyed as a function of time using nile red. To a 6mMolar solution of SDS in water, 1 micromolar solution of nile red in water was added followed by addition of 100 mg of bulk powder of polyaniline. The release of Nile red was studied as a function of time on addition of polymer by monitoring the intensity at 670nm and the result is depicted in figure 10. Decrease in emission intensity as function of time indicates release of guest molecule.
  • Example 8:
  • The disassembly and concomitant release of sequestered guest molecules were surveyed as a function of time using nile red. To a 2mMolar solution of DBS in water, 1 micromolar solution of Nile red in water was added followed by addition of 100 mg of bulk powder of polyaniline. The release of nile red was studied as a function of time on addition of polymer by monitoring the intensity at 670nm and the result is depicted in figure 11. Decrease in emission intensity as function of time indicates release of guest molecule.

Claims (7)

  1. A process for preparation of stimuli induced disassembly of nanocontainer comprising of;
    a) dissolving anionic surfactant in a solvent at its critical micelle concentration (CMC) to form a solution of anionic micelle;
    b) adding a hydrophobic guest molecule to the solution of step (a); and characterised by
    c) disassembly of the anionic micelle and concomitant release of the hydrophobic guest molecule by addition of a cationic oxidized conducting polymer.
  2. The process as claimed in claim 1, wherein the cationic oxidized conducting polymer is selected from polythiophene (PTs), polypyrrole (PPy), Poly(3, 4 ethylenedioxythiophene) and polyaniline (PANI).
  3. The process as claimed in claim 1, wherein the cationic oxidized conducting polymer is in bulk, nano, film, patch or device form.
  4. The process as claimed in claim 2, wherein the cationic oxidized conducting polymer is polyaniline (PANI).
  5. The process as claimed in claim 1, wherein the cationic oxidized conducting polymer is Poly(3, 4 ethylenedioxythiophene).
  6. The process as claimed in claim 1, wherein the guest molecule is selected from drugs, dyes, biomolecules and proteins.
  7. The process as claimed in claim 1, wherein the anionic surfactant is selected from dodecyl benzene sulphonate (DBS) and sodium dodecyl sulphate (SDS).
EP12723933.3A 2011-04-11 2012-04-11 Surface induced disassembly of nano containers Active EP2696853B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1033DE2011 2011-04-11
PCT/IN2012/000259 WO2012140674A1 (en) 2011-04-11 2012-04-11 Surface induced disassembly of nano containers

Publications (2)

Publication Number Publication Date
EP2696853A1 EP2696853A1 (en) 2014-02-19
EP2696853B1 true EP2696853B1 (en) 2019-10-23

Family

ID=46172836

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12723933.3A Active EP2696853B1 (en) 2011-04-11 2012-04-11 Surface induced disassembly of nano containers

Country Status (4)

Country Link
US (1) US20140038879A1 (en)
EP (1) EP2696853B1 (en)
JP (1) JP5992504B2 (en)
WO (1) WO2012140674A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569651B1 (en) * 1999-06-16 2003-05-27 The United States Of America As Represented By The Secretary Of The Army Enzymatic polymerization of anilines or phenols around a template
RU2322263C2 (en) * 2001-11-13 2008-04-20 Астеллас Фарма, Инк. System for prolonged release of soluble drug
KR100907209B1 (en) * 2003-03-20 2009-07-10 주식회사 동진쎄미켐 Method for preparing polyaniline nanoparticles using micro-emulsion polymerization
CA2603853C (en) 2005-04-01 2013-11-19 Intezyne Technologies, Incorporated Polymeric micelles for drug delivery
JP2007023023A (en) * 2005-06-15 2007-02-01 Kanagawa Acad Of Sci & Technol Composition for forming tissue-adhesive medicine-release gel
KR101002654B1 (en) * 2005-10-12 2010-12-20 삼성에스디아이 주식회사 Polymer membrane for fuelcell, method of preparing the same, membrane-electrode assembly comprising the same, and fuel cell system comprising the same
US9175422B2 (en) 2007-01-22 2015-11-03 The United States Of America As Represented By The Secretary Of The Army Polymer-micelle complex as an aid to electrospinning
WO2008141666A1 (en) * 2007-05-24 2008-11-27 Ocas Nv Corrosion protective and electrical conductivity composition free of inorganic solid particles and process for the surface treatment of metallic sheet
WO2010033726A2 (en) 2008-09-17 2010-03-25 The Brigham And Women's Hospital, Inc. Drug delivery composition comprising a self-assembled gelator

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
US20140038879A1 (en) 2014-02-06
WO2012140674A1 (en) 2012-10-18
JP5992504B2 (en) 2016-09-14
JP2014516928A (en) 2014-07-17
EP2696853A1 (en) 2014-02-19

Similar Documents

Publication Publication Date Title
Khan et al. Self-assembled nanostructures
Xu et al. Influence of the drug distribution in electrospun gliadin fibers on drug-release behavior
Mallakpour et al. Polymeric nanoparticles: Recent development in synthesis and application
Riley et al. Colloidal stability and drug incorporation aspects of micellar-like PLA–PEG nanoparticles
Zhang et al. Polymeric core–shell assemblies mediated by host–guest interactions: versatile nanocarriers for drug delivery
Kumari et al. Nanoencapsulation for drug delivery
Verma et al. Self assembled materials: design strategies and drug delivery perspectives
Wu et al. Multi-drug delivery system based on alginate/calcium carbonate hybrid nanoparticles for combination chemotherapy
Cao et al. Generation of nano-sized core–shell particles using a coaxial tri-capillary electrospray-template removal method
Iatridi et al. pH responsive self assemblies from an A n-core-(B-b-C) n heteroarm star block terpolymer bearing oppositely charged segments
Wang et al. Peptide decorated calcium phosphate/carboxymethyl chitosan hybrid nanoparticles with improved drug delivery efficiency
Karuppusamy et al. Role of nanoparticles in drug delivery system: a comprehensive review
Sezgin-bayindir et al. Evaluation of various block copolymers for micelle formation and brain drug delivery: In vitro characterization and cellular uptake studies
CN101792516A (en) Biodegradable polymer vesicles and preparation and application thereof
KR101460204B1 (en) Controlled release gene delivery compositions prepared by solubilization of hydrophilic nucleic acids in organic solvent followed by their encapsulation into hydrophobic nano- and micro-particles and method thereof
Tang et al. Targeted delivery of docetaxel via Pi-Pi stacking stabilized dendritic polymeric micelles for enhanced therapy of liver cancer
Saji Supramolecular organic nanotubes for drug delivery
Xu et al. Glycopolypeptide-encapsulated Mn-doped ZnS quantum dots for drug delivery: fabrication, characterization, and in vitro assessment
Hao et al. Porous hydrophilic core/hydrophobic shell nanoparticles for particle size and drug release control
Wang et al. Rapid self-assembly of block copolymers for flower-like particles with high throughput
Nair et al. Poly (lactide-co-glycolide)–laponite–F68 nanocomposite vesicles through a single-step double-emulsion method for the controlled release of doxorubicin
Kempe et al. Biodegradable polymeric nanoparticles for brain-targeted drug delivery
Gârea et al. Clay–polymer nanocomposites for controlled drug release
EP2696853B1 (en) Surface induced disassembly of nano containers
Ye et al. Self-assembly of DNA-organic hybrid amphiphiles by frame-guided assembly strategies

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20131023

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20151216

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20190617

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602012065064

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1192874

Country of ref document: AT

Kind code of ref document: T

Effective date: 20191115

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20191023

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200224

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200123

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200124

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200224

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602012065064

Country of ref document: DE

PG2D Information on lapse in contracting state deleted

Ref country code: IS

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200223

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1192874

Country of ref document: AT

Kind code of ref document: T

Effective date: 20191023

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

26N No opposition filed

Effective date: 20200724

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200430

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200411

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200430

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200430

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200411

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191023

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230529

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20230425

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20230424

Year of fee payment: 12